Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV-related symptoms

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2024-01-12 DOI:10.1111/hiv.13609
M. José Galindo Puerto, J. Puig, J. A. Pérez-Molina, M. J. Fuster-Ruiz de Apodaca
{"title":"Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV-related symptoms","authors":"M. José Galindo Puerto,&nbsp;J. Puig,&nbsp;J. A. Pérez-Molina,&nbsp;M. J. Fuster-Ruiz de Apodaca","doi":"10.1111/hiv.13609","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>We aimed to assess HIV symptoms from the perspective of both patients and HIV specialists and the impact of discontinuing antiretroviral treatment (ART) on symptomology. We gathered opinions from HIV specialists and people living with HIV about ideal ART parameters and treatment satisfaction.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Ex post-facto cross-sectional surveys were administered to 502 people living with HIV and 101 HIV clinicians in Spain (18 sites).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>The median age of participants with HIV was 43.2 years, 74.5% were male, and 91.6% had an undetectable viral load. The mean time since initiation of ART was 10.2 years. Between 54% and 67% of people living with HIV reported experiencing nervousness or anxiety, sadness, fatigue, sleep problems, or muscle/joint pain during the preceding 4 weeks. However, only 22%–27% of specialists acknowledged the presence of these symptoms. The most bothersome symptoms were related to mental health or the central nervous system. There were significant differences between the burden of symptoms reported by people living with HIV and those acknowledged by specialists. The symptoms that more frequently caused ART discontinuation were depression, dizziness, and sleep problems. Both people living with HIV and specialists prioritized ART efficacy and low toxicity, but their importance ratings differed for 5 of the 11 ART characteristics assessed. People living with HIV rated their satisfaction with ART at a mean (± standard deviation) of 8.9 ± 1.5 out of 10, whereas HIV specialists rated it lower, at 8.3 ± 0.7 (<i>p</i> &lt; 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Despite advances in HIV care and treatment, a large proportion of patients still experience symptoms. HIV specialists may not be fully aware of these. People living with HIV and HIV specialists are, overall, satisfied with ART. However, the importance they place on different ART characteristics may vary.</p>\n </section>\n </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hiv.13609","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

We aimed to assess HIV symptoms from the perspective of both patients and HIV specialists and the impact of discontinuing antiretroviral treatment (ART) on symptomology. We gathered opinions from HIV specialists and people living with HIV about ideal ART parameters and treatment satisfaction.

Methods

Ex post-facto cross-sectional surveys were administered to 502 people living with HIV and 101 HIV clinicians in Spain (18 sites).

Results

The median age of participants with HIV was 43.2 years, 74.5% were male, and 91.6% had an undetectable viral load. The mean time since initiation of ART was 10.2 years. Between 54% and 67% of people living with HIV reported experiencing nervousness or anxiety, sadness, fatigue, sleep problems, or muscle/joint pain during the preceding 4 weeks. However, only 22%–27% of specialists acknowledged the presence of these symptoms. The most bothersome symptoms were related to mental health or the central nervous system. There were significant differences between the burden of symptoms reported by people living with HIV and those acknowledged by specialists. The symptoms that more frequently caused ART discontinuation were depression, dizziness, and sleep problems. Both people living with HIV and specialists prioritized ART efficacy and low toxicity, but their importance ratings differed for 5 of the 11 ART characteristics assessed. People living with HIV rated their satisfaction with ART at a mean (± standard deviation) of 8.9 ± 1.5 out of 10, whereas HIV specialists rated it lower, at 8.3 ± 0.7 (p < 0.001).

Conclusions

Despite advances in HIV care and treatment, a large proportion of patients still experience symptoms. HIV specialists may not be fully aware of these. People living with HIV and HIV specialists are, overall, satisfied with ART. However, the importance they place on different ART characteristics may vary.

艾滋病病毒感染者和艾滋病临床医生对抗逆转录病毒治疗特点和艾滋病相关症状的看法。
目的:我们旨在从患者和艾滋病专家的角度评估艾滋病症状,以及停止抗逆转录病毒疗法对症状的影响:我们旨在从患者和艾滋病专家的角度评估艾滋病症状,以及停止抗逆转录病毒疗法(ART)对症状的影响。我们收集了艾滋病专家和艾滋病感染者对理想抗逆转录病毒疗法参数和治疗满意度的意见:我们对西班牙(18 个地点)的 502 名艾滋病病毒感染者和 101 名艾滋病临床医生进行了事后横断面调查:结果:HIV 感染者的中位年龄为 43.2 岁,74.5% 为男性,91.6% 检测不到病毒载量。开始接受抗逆转录病毒疗法的平均时间为 10.2 年。54%至 67% 的艾滋病病毒感染者表示在过去 4 周内出现过紧张或焦虑、悲伤、疲劳、睡眠问题或肌肉/关节疼痛。然而,只有 22%-27% 的专家承认存在这些症状。最令人烦恼的症状与精神健康或中枢神经系统有关。艾滋病毒感染者报告的症状负担与专家承认的症状负担之间存在明显差异。更常导致抗逆转录病毒疗法中断的症状是抑郁、头晕和睡眠问题。艾滋病病毒感染者和专科医生都将抗逆转录病毒疗法的疗效和低毒性放在首位,但在评估的 11 项抗逆转录病毒疗法特征中,他们对其中 5 项特征的重要性评价有所不同。艾滋病病毒感染者对抗病毒疗法的满意度平均值(± 标准差)为 8.9 ± 1.5(满分 10 分),而艾滋病专家的满意度较低,为 8.3 ± 0.7(P 结论:艾滋病病毒感染者对抗病毒疗法的满意度为 8.9 ± 1.5(满分 10 分):尽管在艾滋病护理和治疗方面取得了进步,但仍有很大一部分患者会出现症状。艾滋病专家可能并不完全了解这些症状。总体而言,艾滋病病毒感染者和艾滋病专家对抗病毒疗法感到满意。但是,他们对不同抗逆转录病毒疗法特点的重视程度可能有所不同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信